Institute of Neurosciences, Mental Health and Addiction
In partnership with
The Amyotrophic Lateral Sclerosis Society of Canada (ALS Canada)
Priority Announcements fund highly rated research applications that are determined to be relevant to specific CIHR research priority areas and do not receive funding through CIHR's regular competitions.
| Important Dates | |
| Opportunity Launched | June 2006 |
| Content Last Updated | July 14, 2006 (Funds Available) |
| October 15, 2006 | Full applications must be courier stamped by this date. Late or incomplete applications will not be considered. |
| April 30, 2007 | Anticipated notification of decision. |
| May 1, 2007 | Earliest start date. |
| Additional Information | Applications are submitted through the October 2006 - Doctoral Research Awards competition. |
| Funds Available | |
| CIHR's contribution to the amount available for this initiative is subject to availability of funds voted annually to CIHR by parliamentary appropriations, and the conditions that may be attached to them. (Updated: 2006-07-14) The maximum amount awarded will be $22,000 per annum, for up to three years:
| |
| Summary | |
| The goal of this Priority Announcement is to announce funding of up to three Doctoral Research Awards in the area of Proteomics, Genomics and Motor Neuron Disease relating to Amyotrophic Lateral Sclerosis (ALS). Researchers must be working in Canada to be eligible for this award. Only one researcher per lab will be eligible to receive funding. | |
Partners
Objectives
Eligibility
Review Process and Evaluation Criteria
General CIHR Guidelines
Conditions of Funding
How to Apply
Contact Information
Description of Partners
The Institute of Neurosciences, Mental Health and Addiction is dedicated to identifying and developing collaborations with other CIHR institute(s), branch(es) or office(s), funding organizations and stakeholders to enhance the availability of funding in their strategic research priority areas and to create, where appropriate, opportunities for knowledge exchange and translation related to the scope of these priority areas. Applicants are invited to visit the Descriptions of Partners to find a list of partners and their respective mandates and/or strategic interests. This list will continue to evolve as new partners join. The specific research foci and requirements for each partner are outlined in the section "Relevant Research Areas".
The objective of this priority announcement is to announce funding of up to three Doctoral Research Awards to be funded by the ALS Society of Canada.
Relevant Research Areas
The ALS Society of Canada will fund applications that are determined to be relevant to the research priority areas described below.
Relevance of the applications to the research priorities will be determined in the following manner:
Prior to peer review, the Institute of Neurosciences, Mental Health and Addiction and the ALS Society of Canada will review applications to determine the relevance, or alignment of the proposed research to the research priority areas described above.
To conduct relevance review, these representatives will have access to the completed relevance form, (see "How to Apply"), anonymized project titles and summaries, provided that applicants have indicated their consent on the "Applicant Consent Form for Use and Disclosure of Personal Information Provided to CIHR for Peer Review," which is included in the application forms.
Upon completion of peer review, the Institute of Neurosciences, Mental Health and Addiction and the ALS Society of Canada will receive the ratings, rankings and peer review committee recommendations on funding level and award term for those applications that 1) are found to be relevant to the specific objectives of the research initiative and the research priority areas described under "Relevant Research Areas"; and 2) are rated within the CIHR fundable range but are not funded through the regular CIHR competition to which they were submitted. These applications will be funded from the top down in order of ranking as far as budgets will allow. Applications that receive a ranking below 3.5 will not be funded.
The relevance review occurs apart from the peer review (scientific review) and has no relationship to the results of peer review. Peer review committees will not be informed of applications submitted for funding through this announcement.
Eligibility criteria for all CIHR research funding programs apply. The business office of the institution of an eligible Nominated Principal Applicant generally administers CIHR funds. Please refer to the Eligibility Requirements for CIHR Grants and Awards regarding the eligibility requirements for individuals and institutions.
Specific to CIHR training awards, please refer to the General Guidelines for Training Programs as well as the Doctoral Research Award program description.
A CIHR peer review committee will evaluate the full applications. The peer review committee members are selected based on suggestions from many sources including the Institute(s) / portfolio(s) and partner(s), following CIHR's Policy on Confidentiality, Conflict of Interest and Privacy Issues in Peer and Relevance Review (CCIP). For information on CIHR's peer review process in general, see Peer Review.
This Priority Announcement will follow the CIHR General Grants and Awards Policies. Applicants are encouraged to demonstrate the use of gender and sex-based analysis in applications.
All conditions specified in CIHR General Grants and Awards Policies shall apply to applications funded through this Priority Announcement. Conditions cover areas such as Applicant and Institutional Responsibilities, Ethics, Official language policy, Access to Information and Privacy Acts, and Acknowledgement of CIHR Support. Successful applicants will be informed of any special financial conditions prior to the release of funds or when they receive CIHR's Authorization for Funding (AFF) document.
Access to Information Act and Privacy Act, and the Personal Information Protection and Electronic Documents Act (PIPEDA)
All personal information collected by CIHR about applicants is used to review applications, to recruit reviewers, to administer and monitor grants and awards, to compile statistics, and to promote and support health research in Canada. Consistent with these purposes, applicants should also expect that information collected by CIHR may be shared as described in Use and Disclosure of Personal Information Provided to CIHR for Peer Review.
CIHR as a federal entity is subject to the Access to Information Act and the Privacy Act, therefore the requirements of these two statutes will apply to all information located in CIHR's premises including, without limitation, cost-sharing agreements related to this priority announcement and all matters pertaining thereto.
While respecting the application of the Privacy Act to federal entities, all signing parties involved in a collaborative agreement will also be bound by the Personal Information Protection and Electronic Documents Act (PIPEDA). All personal information (as identified by the PIPEDA) collected, used or disclosed in the course of any commercial activity under collaborative agreements related to the priority announcement will be collected, used and disclosed in compliance with the PIPEDA.
Applicants are advised to review CIHR's grants and awards policies and guidelines outlined in the CIHR Grants and Awards Guide.
Applications are submitted through the ALS Society of Canada in partnership with the Institute of Neurosciences, Mental Health and Addiction Doctoral Research Award Priority Announcement competition by including a mandatory Relevance Form with your regular Doctoral Research Award application. To select the appropriate application forms, follow the links beside Doctoral Research Award from the list of Application Packages.
Additional Instructions for this Priority Announcement:
For questions about the objectives and relevant research areas:
Dr. Barbara Beckett
Assistant Director, Ottawa
Institute of Neurosciences, Mental Health and Addiction
Telephone: (613) 948-4877
Fax: (613) 954-1800
Email: bbeckett@cihr-irsc.gc.ca
For questions related to specific CIHR competitions and programs, including CIHR funding guidelines, how to apply, and the peer review process contact:
Leah Jurkovic
Program Delivery Coordinator, Partnerships
Canadian Institutes of Health Research
Telephone: (613) 946-0088
Fax: (613) 954-1800
Email: ljurkovic@cihr-irsc.gc.ca
Canadian Institutes of Health Research (CIHR)
CIHR is Canada's major federal funding agency for health research. Its objective is to excel, according to internationally accepted standards of scientific excellence, in the creation of new knowledge and its translation into improved health for Canadians, more effective health services and products and a strengthened Canadian health care system.
CIHR - Institute of Neurosciences, Mental Health and Addiction (INMHA)
INMHA supports research to enhance mental health, neurological health, vision, hearing, and cognitive functioning and to reduce the burden of related disorders through prevention strategies, screening, diagnosis, treatment, support systems, and palliation.
Partners:
Amyotrophic Lateral Sclerosis Society of Canada (ALS Canada)
Amyotrophic Lateral Sclerosis Society of Canada (ALS Canada) was established in 1977, and is the only not-for-profit charitable health-care organization in Canada dedicated solely to finding a cure or effective treatment for ALS. ALS Canada funds medical research into the cause of and cure for ALS (Lou Gehrig's Disease). National support activities also include the development and production of public awareness and educational material and a national newsletter for people with ALS, their families and their health-care providers. The ALS Society of Canada partners with 10 provincial units across Canada providing support and counselling for people with ALS, their families and caregivers.
